This finding is coherent with our previous study, describing a reduced number of CD3 and CD4 T helper cells in cSCC in RDEB patients as compared to patients with primary or secondary cSCC and cSCC in renal transplant patients [5]. The gene discussed is CD4; the disease is skin squamous cell carcinoma.